Students
Dr. Tomohiro Makino (Working at a pharmaceutical company)
Obtained PhD in March 2019 (early acquisition 2.5 years)
Research Topics:Research on business models suitable for precision therapy and precision medicine
brief personal recordMarch 1999 Graduated from RU11 University Graduate School of Agriculture, Master's Program
March 2011, Ph.D. in Science, Graduate School of Medicine and Dentistry, National University
September 2016 Admission to the doctoral program at Ritsumeikan University Graduate School of Technology Management
March 2019 Completed the doctoral program at Ritsumeikan University Graduate School of Technology Management
March 2011, Ph.D. in Science, Graduate School of Medicine and Dentistry, National University
September 2016 Admission to the doctoral program at Ritsumeikan University Graduate School of Technology Management
March 2019 Completed the doctoral program at Ritsumeikan University Graduate School of Technology Management
Research
“Research on business models suitable for precision therapy and precision medicine”
Precision therapy and precision medicine, which have recently been applied in the treatment of cancer and other diseases, are attracting attention as a means of medical care that increases the probability of success in research and development, there were also beneficial to patients. In precision medicine, companion diagnostics (CoDx) and therapeutics are essential to select the appropriate patient population and treat them with the most appropriate drug. To realize the efficiency of this precision medicine development, we are analyzing inter-organizational interactions in the pharmaceutical industry from the perspective of open innovation and studying the optimal organizational and business models.